This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer cross
BAYER FOR PROFESSIONALSYour Resource Portal
  • OPHTHALMOLOGY
  • EYLEA® (aflibercept) 8 mg
  • EYLEA® (aflibercept) 2 mg
  • ONCOLOGY
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • CARDIOLOGY
  • Beyonttra®▼ (acoramidis)
  • Kerendia®▼ (finerenone)
  • Xarelto® (rivaroxaban)
  • WOMEN'S HEALTH
  • Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
  • Jaydess®▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
  • Ophthalmology
  • Oncology
  • Cardiology
  • Women's Health
  • Ophthalmology Resources
  • Oncology Resources
  • Cardiology Resources
  • Women's Health Resources
  • Ophthalmology Events & On Demand Webinars
  • Oncology Events & On Demand Webinars
  • Cardiology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Ophthalmology Learning Zone
  • Oncology Learning Zone
  • Cardiology Learning Zone
  • Women's Health Learning Zone
  • Ophthalmology Podcasts
  • Oncology Podcasts
  • Cardiology Podcasts
  • Women's Health Podcasts
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    learning zone banner

    Ophthalmology Learning Zone

    View more
    Bayer Ophthalmology Masterclass Programme
    Interactive meetings and online resources to refresh your knowledge
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2858, March 2026
    Bitesize OCT Knowledge Checkers
    Test your knowledge of OCT disease biomarkers in this series of OCT images
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-3119, June 2026

    Oncology Learning Zone

    View more
    Request An Interactive Pharmacist’s Guide
    NUBEQA® (darolutamide)
    NUBEQA Prescribing Information
    PP-NUB-GB-2388, May 2025
    NUBEQA® (darolutamide) Drug-Drug Interactions Learning Guide
    NUBEQA Prescribing Information
    PP-NUB-GB-3128, August 2026
    Module 4: MI Course
    Xofigo®▼ (radium-223 dichloride) | NUBEQA® (darolutamide)
    Xofigo Prescribing Information
    NUBEQA Prescribing Information
    RP-NUB-GB-0713, January 2025
    Module 3: MI Course
    Xofigo®▼ (radium-223 dichloride) | NUBEQA® (darolutamide)
    Xofigo Prescribing Information
    NUBEQA Prescribing Information
    RP-NUB-GB-0712, January 2025